BMJ  2008;336:1056-1058 (10 May), doi:10.1136/bmj.39541.534109.BE (published 24 April 2008)

Research

Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study

¹ Academic Unit of Obstetrics and Gynaecology, St Mary’s Hospital, University of Manchester, Manchester M13 OJH, ² Health Methodology Research Group, University of Manchester, ³ Public Health Department, Stockport Primary Care Trust, Stockport, ⁴ Public Health Department, Bury Primary Care Trust, Bury, ⁵ Greater Manchester Health Protection Unit, Eccles

Objective To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls.

Design Prospective cohort study.

Setting 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom.

Participants 2817 schoolgirls in year 8 (12 and 13 year olds).

Intervention Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year.

Main outcome measures Vaccine uptake for doses 1 and 2 of a three dose schedule.

Results Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents’ refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported.

Conclusion Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

Related Articles

Effect of ethnic group should be clarified

Gee Yen Shin
BMJ 2008 336: 1146. [Extract] [Full Text] [PDF]

Some issues around consent remain unresolved

Elizabeth C F Brown
BMJ 2008 336: 1146. [Extract] [Full Text] [PDF]

HPV vaccination in the UK

Jo Waller and Jane Wardle
BMJ 2008 336: 1028-1029. [Extract] [Full Text] [PDF]

Challenges of implementing human papillomavirus (HPV) vaccination policy

Angela E Raffle
BMJ 2007 335: 375-377. [Extract] [Full Text] [PDF]

Comparison of social distribution of immunisation with measles, mumps, and rubella vaccine, England, 1991-2001

Elizabeth Middleton and Deborah Baker
BMJ 2003 326: 854. [Full Text] [PDF]

This article has been cited by other articles:

• (2008). HPV Vaccine: Uptake and Obstacles. JWatch Women's Health 2008: 4-4 [Full text]  
• Shin, G. Y. (2008). Effect of ethnic group should be clarified. BMJ 336: 1146-1146 [Full text]  
• Brown, E. C F (2008). Some issues around consent remain unresolved. BMJ 336: 1146-1146 [Full text]  
• Waller, J., Wardle, J. (2008). HPV vaccination in the UK. BMJ 336: 1028-1029 [Full text]  

Rapid Responses:

Read all Rapid Responses

Urgent need for uptake data on 3 doses of HPV vaccine

Padmanabhan Badrinath
bmj.com, 26 Apr 2008 [Full text]

If liberty means anything at all, it means the right to tell people what they do not want to hear.

BM Hegde
bmj.com, 27 Apr 2008 [Full text]

An encouraging trial

Peter M English
bmj.com, 2 May 2008 [Full text]

Clarification on effect of ethnicity would be welcome

Gee Yen Shin
bmj.com, 12 May 2008 [Full text]

HPV vaccination: unresolved issues around consent

Elizabeth C.F. Brown
bmj.com, 13 May 2008 [Full text]

HPV vaccination in the United Kingdom: Early days..

Emmanuel Agogo
bmj.com, 14 May 2008 [Full text]